Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Live webinar from Singapore
- Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19
Research Partnership
- Webinar
- Every voice counts in MedTech – Getting more with less via an innovative trade-off technique
Research Partnership
- Guide
- UX research
Research Partnership
- Article: Why pharma must trust the science of behaviour
Research Partnership
- Case study
- Using qualitative conjoint to assess willingness-to-pay
Research Partnership
- Consumer health specialist joins Research Partnership Inc
- Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.
Research Partnership
